Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):548.
   Web of Science ®Google Scholar
• Ward EM, Sherman RL, Henley SJ, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20–49 years. J Natl Cancer Inst. 2019;111(12):1279–1297. doi:10.1093/jnci/djz106
   PubMedGoogle Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–638. doi:10.1038/nri.2016.90
   PubMed Web of Science ®Google Scholar
• Berk-Krauss J, Stein JA, Weber J, Polsky D, Geller AC. New Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986–2016. Am J Public Health. 2020;110(5):731–733. doi:10.2105/AJPH.2020.305567
   PubMed Web of Science ®Google Scholar
• Mishra H, Mishra PK, Ekielski A, Jaggi M, Iqbal Z, Talegaonkar S. Melanoma treatment: from conventional to nanotechnology. J Cancer Res Clin Oncol. 2018;144(12):2283–2302. doi:10.1007/s00432-018-2726-1
   PubMed Web of Science ®Google Scholar
• Bommareddy PK, Silk AW, Kaufman HL. Intratumoral Approaches for the Treatment of Melanoma. Cancer j. 2017;23(1):40–47. doi:10.1097/PPO.0000000000000234
   PubMed Web of Science ®Google Scholar
• Huang Q, Yan J, Agami R. Long non-coding RNAs in metastasis. Cancer Metastasis Rev. 2018;37(1):75–81. doi:10.1007/s10555-017-9713-x
   PubMed Web of Science ®Google Scholar
• Ramilowski JA, Yip CW, Agrawal S, et al. Functional annotation of human long noncoding RNAs via molecular phenotyping. Genome Res. 2020;30(7):1060–1072. doi:10.1101/gr.254219.119
   Web of Science ®Google Scholar
• Li D, Tang X, Li M, Zheng Y. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p. J Cell Biochem. 2019;120(8):12290–12299. doi:10.1002/jcb.28493
   PubMed Web of Science ®Google Scholar
• Jin Z, Jiang S, Jian S, Shang Z. Long noncoding RNA MORT overexpression inhibits cancer cell proliferation in oral squamous cell carcinoma by downregulating ROCK1. J Cell Biochem. 2019;120(7):11702–11707. doi:10.1002/jcb.28449
   PubMed Web of Science ®Google Scholar
• Wu L, Zhu L, Li Y, Zheng Z, Lin X, Yang C. LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis. Cancer Cell Int. 2020;20(1):12. doi:10.1186/s12935-019-1087-4
   PubMed Web of Science ®Google Scholar
• Tian Y, Zhang X, Hao Y, Fang Z, He Y. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res. 2014;24(4):335–341. doi:10.1097/CMR.0000000000000080
   PubMed Web of Science ®Google Scholar
• Atianand MK, Caffrey DR, Fitzgerald KA. Immunobiology of Long Noncoding RNAs. Annu Rev Immunol. 2017;35(1):177–198. doi:10.1146/annurev-immunol-041015-055459
   PubMed Web of Science ®Google Scholar
• Chen YG, Satpathy AT, Chang HY. Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 2017;18(9):962–972. doi:10.1038/ni.3771
   PubMed Web of Science ®Google Scholar
• Peng D, Wang L, Li H, et al. An immune infiltration signature to predict the overall survival of patients with colon cancer. IUBMB Life. 2019;71(11):1760–1770. doi:10.1002/iub.2124
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang Q, Fu C, Jiang C, Ma S. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma. Ann Transl Med. 2019;7(23):730. doi:10.21037/atm.2019.11.117
   Web of Science ®Google Scholar
• Wei Z-W, Wu J, Huang W-B, et al. Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour. EBioMedicine. 2020;57:102850. doi:10.1016/j.ebiom.2020.102850
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Xu Y, Wu X, Zhou Y, Mo J. Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma. J Cell Physiol. 2020;235(12):9304–9316. doi:10.1002/jcp.29730
   PubMed Web of Science ®Google Scholar
• Li Z, Li Y, Wang X, Yang Q. Identification of a Six-Immune-Related Long Non-coding RNA Signature for Predicting Survival and Immune Infiltrating Status in Breast Cancer. Front Genet. 2020;11:680. doi:10.3389/fgene.2020.00680
   PubMed Web of Science ®Google Scholar
• Jiang Y, Gou X, Wei Z, et al. Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma. Cancer Cell Int. 2020;20(1):166. doi:10.1186/s12935-020-01242-7
   PubMed Web of Science ®Google Scholar
• Song Y, Jin D, Chen J, et al. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer. Aging. 2020;12(12):12051–12073. doi:10.18632/aging.103369
   PubMedGoogle Scholar
• Lv Y, Lin S-Y, Hu -F-F, et al. Landscape of cancer diagnostic biomarkers from specifically expressed genes. #N/A. 2020;21(6):2175–2184.
   Google Scholar
• Zhang W, Zhang J, Yan W, et al. Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer. 2013;119(4):814–824. doi:10.1002/cncr.27826
   PubMed Web of Science ®Google Scholar
• Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004;350(18):1828–1837. doi:10.1056/NEJMoa032520
   PubMed Web of Science ®Google Scholar
• Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–344. doi:10.1111/j.0006-341X.2000.00337.x
   PubMed Web of Science ®Google Scholar
• Jenkins RW, Fisher DE. Treatment of Advanced Melanoma in 2020 and Beyond. J Invest Dermatol. 2021;141(1):23–31. doi:10.1016/j.jid.2020.03.943
   PubMed Web of Science ®Google Scholar
• Darmawan CC, Jo G, Montenegro SE, et al. Early detection of acral melanoma: a review of clinical, dermoscopic, histopathologic, and molecular characteristics. J Am Acad Dermatol. 2019;81(3):805–812. doi:10.1016/j.jaad.2019.01.081
   PubMed Web of Science ®Google Scholar
• Gruss I, Twardowski JP, Cierpisz M. The Effects of Locality and Host Plant on the Body Size of (Thysanoptera: aeolothripidae) in the Southwest of Poland. Insects. 2019;10(9):266. doi:10.3390/insects10090266
   Web of Science ®Google Scholar
• Yang S, Xu J, Zeng X. A six-long non-coding RNA signature predicts prognosis in melanoma patients. Int J Oncol. 2018;52(4):1178–1188. doi:10.3892/ijo.2018.4268
   Web of Science ®Google Scholar
• Shen Y, Peng X, Shen C. Identification and validation of immune-related lncRNA prognostic signature for breast cancer. Genomics. 2020;112(3):2640–2646. doi:10.1016/j.ygeno.2020.02.015
   PubMed Web of Science ®Google Scholar
• Hong W, Liang L, Gu Y, et al. Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma. Mol Ther Nucleic Acids. 2020;22:937–947. doi:10.1016/j.omtn.2020.10.002
   PubMedGoogle Scholar
• Wei C, Liang Q, Li X, et al. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. J Cell Biochem. 2019;120(9):14916–14927. doi:10.1002/jcb.28754
   PubMed Web of Science ®Google Scholar
• Guo ZH, Yao LT, Guo AY. Clinical and biological impact of LINC02544 expression in breast cancer after neoadjuvant chemotherapy. Eur Rev Med Pharmacol Sci. 2020;24(20):10573–10585. doi:10.26355/eurrev_202010_23413
   Web of Science ®Google Scholar
• Jin D, Song Y, Chen Y, Zhang P. Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma. #N/A. 2020;2020:7929132.
   Google Scholar
• Yu S, Li N, Wang J, et al. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma. Clin Ther. 2020;42(3):439–447. doi:10.1016/j.clinthera.2020.01.012
   PubMed Web of Science ®Google Scholar
• Lv Y, Wei W, Huang Z, et al. Long non-coding RNA expression profile can predict early recurrence in hepatocellular carcinoma after curative resection. Hepatology Res. 2018;48(13):1140–1148. doi:10.1111/hepr.13220
   PubMed Web of Science ®Google Scholar
• Zhong Z, Hong M, Chen X, et al. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. BMC Med Genomics. 2020;13(1):57. doi:10.1186/s12920-020-0707-0
   PubMed Web of Science ®Google Scholar
• Cheng F, Liu J, Zhang Y, et al. Long Non-Coding RNA UBA6-AS1 Promotes the Malignant Properties of Glioblastoma by Competitively Binding to microRNA-760 and Enhancing Homeobox A2 Expression. Cancer Manag Res. 2021;13:379–392. doi:10.2147/CMAR.S287676
   PubMed Web of Science ®Google Scholar
• Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220. doi:10.1186/s13059-017-1349-1
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Finotello F, Mayer C, Plattner C, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11(1):34. doi:10.1186/s13073-019-0638-6
   PubMed Web of Science ®Google Scholar
• Plattner C, Finotello F, Rieder D. Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quanTIseq. Methods Enzymol. 2020;636:261–285.
   PubMed Web of Science ®Google Scholar
• Dienstmann R, Villacampa G, Sveen A, et al. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer. Ann Oncol. 2019;30(10):1622–1629. doi:10.1093/annonc/mdz287
   PubMed Web of Science ®Google Scholar
• Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017;6:6. doi:10.7554/eLife.26476
   Web of Science ®Google Scholar
• Tamminga M, Hiltermann TJN, Schuuring E, Timens W, Fehrmann RS, Groen HJ. Immune microenvironment composition in non-small cell lung cancer and its association with survival. Clin Transl Immunol. 2020;9(6):e1142. doi:10.1002/cti2.1142
   PubMed Web of Science ®Google Scholar
• Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
   PubMedGoogle Scholar
• Zhang H, Li R, Cao Y, et al. Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients. Ann Surg. 2020. doi:10.1097/SLA.0000000000004037
   Web of Science ®Google Scholar
• Qian J, Olbrecht S, Boeckx B, et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 2020;30(9):745–762. doi:10.1038/s41422-020-0355-0
   PubMed Web of Science ®Google Scholar